Ophthalmology, Glaucoma Specialist · Caguas, PR
NPI
1578907614
Since 2013
Specialty
Ophthalmology, Glaucoma Specialist
Code 207WX0009X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Plaza Bairoa, Pr #1 Ave Sakura
Caguas, PR, 00725
Phone (787) 641-3030
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
301 services
Medicare patients, 2024
45
Average age 76
Drug cost, 2024
$1.8M
16,717 prescriptions
Company payments, 2025
$7,332
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria G Velazquez Lamela was code 92014 (ophthalmological e&m), 86 times for 38 patients. In total Maria G Velazquez Lamela billed 301 services in 25 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 86 | 38 | $85.13 | $7,321 |
| 92250 Angiography | Office | 43 | 32 | $25.77 | $1,108 |
| 92083 Vision, Hearing, and Speech Services | Office | 41 | 34 | $43.93 | $1,801 |
| 92133 Computerized Ophthalmic Imaging | Office | 20 | 19 | $26.86 | $537 |
| 92134 Computerized Ophthalmic Imaging | Office | 19 | 18 | $26.85 | $510 |
By year: 2022 $21K for 290 services; 2023 $30K for 416 services; 2024 $22K for 301 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria G Velazquez Lamela prescribed most often to Medicare patients was Latanoprost, with 2,674 prescriptions and refills. In total Maria G Velazquez Lamela wrote 16,717 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 2,674 | 3,169 | 505 | $33K |
| Lumigan Bimatoprost | 2,536 | 3,032 | 497 | $735K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 2,197 | 3,861 | 593 | $73K |
| Brimonidine Tartrate Generic | 1,444 | 1,766 | 329 | $56K |
| Prednisolone Acetate Generic | 1,328 | 1,576 | 474 | $87K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 806 | 932 | 154 | $138K |
| Dorzolamide Hcl Generic | 767 | 1,223 | 196 | $22K |
| Timolol Maleate Generic | 761 | 992 | 183 | $11K |
| Ofloxacin Generic | 661 | 664 | 377 | $15K |
| Combigan Brimonidine Tartrate/Timolol | 498 | 546 | 96 | $119K |
| Ketorolac Tromethamine Generic | 392 | 398 | 221 | $8,740 |
| Acetazolamide Generic | 355 | 374 | 98 | $16K |
| Alphagan P Brimonidine Tartrate | 281 | 318 | 77 | $67K |
| Simbrinza Brinzolamide/Brimonidine Tart | 213 | 270 | 50 | $45K |
| Atropine Sulfate Generic | 172 | 186 | 118 | $5,814 |
Brand drugs: 6,997 claims; generic drugs: 9,720 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria G Velazquez Lamela $7,332 ($7,332 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $6,411.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.